Vivo Capital, LLC Arcutis Biotherapeutics, Inc. Transaction History

Vivo Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$14.98 - $25.5 $6.5 Million - $11.1 Million	-433,585 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$24.42 - $34.75 $7.59 Million - $10.8 Million	-310,785 Reduced 41.75%	433,585 $11.8 Million
Q1 2021 May 17, 2021	SELL	$24.47 - $36.98 $3 Million - $4.54 Million	-122,800 Reduced 14.16%	744,370 $21.5 Million
Q4 2020 Feb 16, 2021	SELL	$17.82 - $31.73 $4.39 Million - $7.81 Million	-246,095 Reduced 22.11%	867,170 $24.4 Million
Q3 2020 Nov 13, 2020	SELL	$23.44 - $32.28 $4.13 Million - $5.68 Million	-176,095 Reduced 13.66%	1,113,265 $32.6 Million

Q2 2020 Aug 14, 2020	SELL	$24.48 - $36.56 $9.72 Million - $14.5 Million	-397,167 Reduced 23.55%	1,289,360 $39 Million
Q1 2020 May 15, 2020	BUY	$18.5 - $36.9 $31.2 Million - $62.2 Million	1,686,527 New	1,686,527 $50.3 Million

172

126M

498K

1.64M

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $631M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.